Clinical Trials on 胰腺炎,急性坏死 in Australia
总计573个结果
-
University Medical Center GoettingenLudwig-Maximilians - University of Munich; University of Leipzig; University Hospital Heidelberg; Technical University of Munich 和其他合作者招聘中
-
Aliye UcNational Cancer Institute (NCI); National Institute of Diabetes and Digestive and Kidney Diseases...完全的
-
Medical University of ViennaWilheminenspital der Stadt Wien完全的
-
Boston Scientific Corporation完全的
-
Imago BioSciences, Inc., a subsidiary of Merck...完全的
-
University of SydneyMelbourne Health; Royal Brisbane and Women's Hospital未知
-
Shanghai Fosun Pharmaceutical Industrial Development...终止
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene Corporation完全的骨髓增生异常综合征 (MDS) | 急性髓系白血病 (AML)澳大利亚
-
Eilean Therapeutics尚未招聘
-
Novartis Pharmaceuticals完全的
-
Race Oncology LtdAstex Pharmaceuticals, Inc.撤销急性髓性白血病 | 慢性粒单核细胞白血病 | 复发性急性髓性白血病 | 难治性急性髓性白血病 | 高危骨髓增生异常综合征澳大利亚
-
Australian and New Zealand Intensive Care Research...National Health and Medical Research Council, Australia; The Alfred; National Heart Foundation... 和其他合作者招聘中
-
University of CalgaryThe George Institute for Global Health, Australia尚未招聘急性缺血性中风 AIS | 中风,急性,缺血性中风 | 急性中风加拿大, 澳大利亚
-
Monash UniversityNational Heart Foundation, Australia; Ambulance Victoria; Department of Health, Victorian Government完全的
-
Medical University of GrazFresenius Medical Care North America完全的
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Melbourne Health招聘中骨髓增生异常综合征 | 白血病,骨髓,急性 | 浆细胞骨髓瘤 | 非霍奇金淋巴瘤 | 白血病,淋巴细胞,急性,L1 | 白血病,淋巴细胞,急性,L2澳大利亚
-
Institut de Recherches Internationales ServierADIR, a Servier Group company主动,不招人
-
Peter MacCallum Cancer Centre, Australia未知多发性骨髓瘤 | 骨髓增生异常综合症 | 急性髓性白血病澳大利亚
-
Austin HealthNorthern Health and Social Care Trust; Western Hospital, Australia未知
-
Therapeutic Advances in Childhood Leukemia ConsortiumEnzon Pharmaceuticals, Inc.终止淋巴细胞白血病,急性,儿童 | 白血病,淋巴细胞,急性 | 淋巴细胞白血病,急性 | 白血病,淋巴细胞,急性,T 细胞美国, 澳大利亚
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Astellas Pharma Global Development, Inc.不再可用急性髓系白血病 (AML) | FMS 样酪氨酸激酶 3 (FLT3) 突变澳大利亚, 意大利, 英国
-
Bayside HealthAustralian and New Zealand College of Anaesthetists完全的
-
The Prince Charles HospitalSanofi; Merck Sharp & Dohme LLC完全的
-
Stanford University完全的
-
Novartis Pharmaceuticals终止